PHI creates a subsidiary for the anticipated EU patent concerning synthetic antibodies
Phase Holographic Imaging (PHI) announces today that the European Patent Office intends to grant application EP329447 Molecularly Imprinted Polymers with minor changes. The Company’s corresponding patents in the US and Japan concerning synthetic antibodies were granted in 2020 and 2022, respectively. With a Europan grant process on track as well, PHI has decided to